YOLFTbeta
Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc

ADIL · NASDAQ · Healthcare / Biotechnology

4.05USD-0.04 (-1.10%)

Price History

Full chart

Market Stats

Previous Close4.10
Open3.95
Day Range3.95 – 4.30
52-Week Range1.31 – 10.75
Volume7.04K
Market Cap12.38M
P/E (TTM)0.00
Forward P/E0.00
EPS-17.71
Dividend Yield0.00%
Beta1.39
50-Day Avg4.61
200-Day Avg3.54

About

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Cary John Claiborne MBA
  • Employees5
  • Headquarters4870 Sadler Road, Glen Allen, VA, United States, 23060, USA
  • Websitehttps://www.adial.com

Leadership

  • Mr. Cary John Claiborne MBACEO, President & Director · b. 1961
  • Mr. Vinay Shah A.C.A., C.P.A., M.B.A.CFO & Treasurer · b. 1962

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue00000000000
Cost of Revenue56556556556356556455.11K60.50K564565565
Gross Profit-565-565-565-563-565-564-55.11K-60.50K-564-565-565
Operating Expense818.69K410.24K994.72K6.99M8.24M10.93M19.23M10.80M6.89M8.28M7.80M
Operating Income-819.26K-410.81K-995.29K-6.99M-8.24M-10.93M-19.29M-10.86M-6.89M-8.28M-7.80M
EBITDA-817.43K-410.00K-994.35K-6.98M-8.59M-10.93M-17.69M-10.80M-7.00M-13.20M-7.98M
Net Income-817.99K-420.20K-1.14M-11.63M-8.59M-10.86M-19.42M-12.73M-7.00M-13.20M-7.98M
R&D322.11K146.14K182.11K368.46K3.97M5.85M8.40M1.95M1.27M3.23M2.62M
Interest Expense09.64K144.54K1.17M003.61M585.21K---

Balance Sheet

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets216.22K151.53K34.55K4.70M7.68M5.49M7.63M5.73M4.74M5.04M6.80M
Total Liabilities53.08K255.02K1.03M257.97K539.05K1.51M4.13M2.46M653.51K975.86K1.52M
Total Equity163.15K-103.49K-997.55K4.44M7.14M3.99M3.51M3.28M4.08M4.07M5.28M
Cash162.38K87.99K18.25K3.87M6.78M4.40M6.06M4.00M2.83M3.75M5.88M
Total Debt-234.25K689.26K---256.96K207.38K---
Net Debt-162.38K146.26K671.02K-3.87M-6.78M-4.40M-5.81M-3.79M-2.83M-3.75M-5.88M

Cash Flow

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-465.22K-274.38K-494.86K-2.50M-6.34M-7.63M-11.95M-11.19M-6.81M-6.92M-6.49M
Investing Cash Flow35.12K35.12K35.12K-350.00K-350.00K-350.00K-34.02K-1.50M-150.00K
Financing Cash Flow200.00K200.00K390.00K6.35M9.25M5.61M13.64M9.13M4.13M7.85M8.47M
Capital Expenditure00064.61K64.61K64.61K64.61K56.81M03
Free Cash Flow-465.22K-274.38K-494.86K-2.50M-6.34M-7.63M-12.01M-11.19M-6.81M-6.92M-6.49M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.54%100.00%100.00%100.00%100.00%

Earnings

Report DateJun 21, 2017Sep 7, 2017Nov 22, 2017Jul 30, 2018Nov 14, 2018Feb 19, 2019May 13, 2019Aug 13, 2019Nov 14, 2019Mar 20, 2020May 14, 2020Aug 13, 2020Nov 13, 2020Mar 22, 2021May 17, 2021Aug 12, 2021Nov 15, 2021Mar 28, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 30, 2023May 12, 2023Aug 21, 2023Nov 14, 2023Feb 20, 2024Apr 1, 2024Aug 13, 2024Nov 13, 2024Mar 31, 2025May 14, 2025Aug 13, 2025Nov 13, 2025Mar 26, 2026May 8, 2026Aug 14, 2026Nov 12, 2026
EPS Estimate0.000.000.00--162.50-112.50-106.25-143.75-181.25-118.75--112.50-112.50-0.25-93.75-128.12-139.58-0.21-106.25-91.67-112.50-0.15-87.50-56.25-28.37-0.76-19.00-9.75-11.00-0.33-12.37-5.50-3.50-2.13-2.25-0.91-
EPS Actual-0.03-0.04-0.04-0.06-528.94-118.75-169.75-131.25-106.25-118.75-0.22-100.00-150.00-0.24-187.50-156.25-137.50-0.28-81.25-100.00-75.00-0.10-68.75-33.25-28.50-1.35-9.25-14.75-9.50-0.15-8.50-4.50-2.00-11.48-1.48-11.25-
Surprise-----225.50%-5.56%-59.76%8.70%41.38%0.00%-11.11%-33.33%4.00%-100.00%-21.96%1.49%-33.33%23.53%-9.09%33.33%30.00%21.43%40.89%-0.46%-77.63%51.32%-51.28%13.64%54.55%31.29%18.18%42.86%-438.97%34.22%-1136.26%-
Timing---After-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap12.38M
Enterprise Value-16.63M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book3.52
EPS-17.71
Book Value-14.62
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-11.49M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-2011.64%
Return on Assets-40.02%
Shares Outstanding2.93M
Shares Float1.82M
Beta1.39
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 3 analystsTarget 8.33
  • Strong Buy
    2
  • Hold
    1

Ownership Breakdown

Institutions
29.85%
Insiders
7.08%
Retail / Other
63.07%

Top Institutional Holders

  • Citadel Advisors Llc
    29.55K1.13%
  • Geode Capital Management, LLC
    24.25K0.92%
  • China Universal Asset Mgmt Co.Ltd
    8.00K0.30%
  • Vanguard Fiduciary Trust Co
    5.88K0.22%
  • Manchester Capital Management LLC
    1.92K0.07%
  • Tower Research Capital LLC
    1.36K0.05%
  • BlackRock Inc
    1.11K0.04%
  • UBS Group AG
    5420.02%
  • Vanguard Capital Management, LLC
    3610.01%
  • Raffa Wealth Management LLC
    830.00%
  • Morgan Stanley - Brokerage Accounts
    500.00%
  • SBI Securities Co Ltd
    470.00%
  • Caitong International Asset Management Co., Limited.
    150.00%
  • Wells Fargo & Co
    60.00%
  • Northwestern Mutual Wealth Management Co
    40.00%
  • HARBOUR INVESTMENTS, INC.
    30.00%
  • Abound Wealth Management
    10.00%

Top Fund Holders

  • Fidelity Extended Market Index
    11.83K0.45%
  • China Universal Gbl YLBJ QDII CNH
    8.00K0.30%
  • Fidelity Total Market Index
    3100.01%

Stock Splits

  • Feb 6, 20261:25
  • Aug 7, 20231:25